HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Comparative Effectiveness Research Funds Included In HHS Approps Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

The Agency for Healthcare Research & Quality would receive $15 mil. for outcomes research in the Senate bill funding HHS for fiscal year 2005. The corresponding House measure, however, includes no resources for comparative research.

You may also be interested in...



AHRQ Seeks Topics For Evidence-Based Practice Centers

Agency for Healthcare Research & Quality is soliciting nominations for topics of evidence reports and technology assessments relating to the "prevention, diagnosis, treatment and management of common diseases and clinical conditions" and "the organization and financing of health care."

Endo’s Lidoderm Mailings Draw FDA Warning Letter For Unsubstantiated Claims

FDA asks Endo to disseminate “corrective messages” to doctors who received the violative promotional materials, which the agency says omit risk information and contain unsubstantiated effectiveness claims.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060571

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel